Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
6
×
san francisco blog main
boston blog main
boston top stories
clinical trials
new york blog main
san francisco top stories
new york top stories
san diego blog main
biotech
bristol-myers squibb
gene therapy
roche
san diego top stories
boston
clinical data
merck
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acadia pharmaceuticals
adverum biotechnologies
aimmune
alk
allergan
amgen
astellas pharma
atlas venture
audentes therapeutics
avalon ventures
aveo oncology
What
data
6
×
drug
medical
cancer
lung
therapeutics
advanced
ago
analytics
annual
approved
arrival
award
bio
biofourmis
biotechs
breast
cancer's
clinical
close
conference
considering
death
decades
dems
devices
digital
disease
diseases
dyne
early
employs
esmo
european
expected
experimental
eyes
fatty
forward
gene
Language
unset
Current search:
data
×
" national top stories "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front